-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Buy on CeriBell, Raises Price Target to $26

Benzinga·08/11/2026 15:46:51
Listen to the news
Canaccord Genuity analyst William Plovanic maintains CeriBell (NASDAQ:CBLL) with a Buy and raises the price target from $25 to $26.